151 studies found for:    "Idiopathic pulmonary fibrosis"
Show Display Options
Rank Status Study
21 Terminated
Has Results
ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Hypertension
Interventions: Drug: Ambrisentan;   Drug: Placebo
22 Unknown  Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Behavioral: Pulmonary Rehabilitation
23 Completed CPAP Therapy in Patients With Idiopathic Pulmonary Fibrosis and Sleep Apnea
Conditions: Obstructive Sleep Apnea;   Idiopathic Pulmonary Fibrosis
Intervention: Procedure: Continuous Positive Airway Pressure (CPAP)
24 Recruiting Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Omeprazole;   Drug: Matched placebo
25 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Pulmonary Hypertension
Intervention: Drug: sildenafil
26 Unknown  Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: minocycline
27 Recruiting Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: No Intervention
28 Completed
Has Results
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Bosentan
29 Terminated A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Fibrosis;   Fibrosis;   Interstitial Lung Disease;   Lung Diseases, Interstitial
Interventions: Drug: CC-930;   Other: Placebo
30 Not yet recruiting Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis
Intervention:
31 Completed Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study
Conditions: Idiopathic Pulmonary Fibrosis;   Lung Disease;   Pulmonary Fibrosis
Intervention: Drug: Imatinib Mesylate (Gleevec)
32 Completed Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Pulmonary rehabilitation
33 Unknown  Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Fibrosis
Interventions: Drug: Sildenafil;   Drug: Losartan;   Drug: Sildenafil and Losartan;   Drug: Placebo pill
34 Recruiting Idiopathic Pulmonary Fibrosis Registry for Future Studies
Conditions: Lung Disease, Interstitial;   Idiopathic Pulmonary Fibrosis
Intervention:
35 Completed Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: zileuton;   Drug: azathioprine/prednisone
36 Not yet recruiting Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Dyspnoea;   Anxiety;   Depression
Intervention:
37 Recruiting Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: BMS-986020;   Drug: Placebo matching with BMS-986020
38 Terminated
Has Results
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: warfarin;   Drug: placebo
39 Available Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: nintedanib
40 Completed
Has Results
Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Pirfenidone;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years